200 related articles for article (PubMed ID: 20465457)
1. Recurrence in medulloblastoma - influence of clinical, histological and immunohistochemical factors.
Srikantha U; Balasubramaniam A; Santosh V; Somanna S; Bhagavatula ID; Ashwathnarayana CB
Br J Neurosurg; 2010 Jun; 24(3):280-8. PubMed ID: 20465457
[TBL] [Abstract][Full Text] [Related]
2. A clinicobiological model predicting survival in medulloblastoma.
Ray A; Ho M; Ma J; Parkes RK; Mainprize TG; Ueda S; McLaughlin J; Bouffet E; Rutka JT; Hawkins CE
Clin Cancer Res; 2004 Nov; 10(22):7613-20. PubMed ID: 15569993
[TBL] [Abstract][Full Text] [Related]
3. Reappraisal of clinical outcome in adult medulloblastomas with emphasis on patterns of relapse.
Chargari C; Feuvret L; Levy A; Lamproglou I; Assouline A; Hemery C; Ghorbal L; Lopez S; Tep B; G GB; Lang P; Laigle-Donadey F; Cornu P; Mazeron JJ; Simon JM
Br J Neurosurg; 2010 Aug; 24(4):460-7. PubMed ID: 20726753
[TBL] [Abstract][Full Text] [Related]
4. Calbindin-d(28k): a marker of recurrence for medulloblastomas.
Pelc K; Vincent S; Ruchoux MM; Kiss R; Pochet R; Sariban E; Decaestecker C; Heizmann CW
Cancer; 2002 Jul; 95(2):410-9. PubMed ID: 12124842
[TBL] [Abstract][Full Text] [Related]
5. [Medulloblastoma in children].
Hideghety K; Kerr C; Debrigode C; Dubois JB
Bull Cancer Radiother; 1994; 81(2):143-6. PubMed ID: 7702894
[No Abstract] [Full Text] [Related]
6. [Medulloblastoma of the cerebellum. Apropos of 120 cases from 1953 to 1982].
Baranzelli MC; Demaille MC; Dhellemmes P; Madelain M; Nuyts JP
Ann Pediatr (Paris); 1986 Feb; 33(2):93-8. PubMed ID: 3963719
[No Abstract] [Full Text] [Related]
7. Anti-apoptotic and growth-promoting markers in adult medulloblastomas.
Ongürü O; Karslioglu Y; Ozcan A; Celik E
Clin Neuropathol; 2010; 29(6):384-9. PubMed ID: 21073843
[TBL] [Abstract][Full Text] [Related]
8. Prediction of prognosis in children with medulloblastoma by using immunohistochemical analysis and tissue microarray.
Shim KW; Joo SY; Kim SH; Choi JU; Kim DS
J Neurosurg Pediatr; 2008 Mar; 1(3):196-205. PubMed ID: 18352763
[TBL] [Abstract][Full Text] [Related]
9. Histopathological prognostic factors in medulloblastoma: high expression of survivin is related to unfavourable outcome.
Haberler C; Slavc I; Czech T; Gelpi E; Heinzl H; Budka H; Urban C; Scarpatetti M; Ebetsberger-Dachs G; Schindler C; Jones N; Klein-Franke A; Maier H; Jauk B; Kiefer A; Hainfellner JA
Eur J Cancer; 2006 Nov; 42(17):2996-3003. PubMed ID: 16996732
[TBL] [Abstract][Full Text] [Related]
10. C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer.
Logullo AF; Lopes AB; Nonogaki S; Soares FA; Netto MM; Nishimoto IN; Brentani MM
Oncol Rep; 2007 Jul; 18(1):121-6. PubMed ID: 17549356
[TBL] [Abstract][Full Text] [Related]
11. Medulloblastoma in adults: clinical characteristics and treatment.
Brandes AA; Palmisano V; Monfardini S
Cancer Treat Rev; 1999 Feb; 25(1):3-12. PubMed ID: 10212586
[TBL] [Abstract][Full Text] [Related]
12. Microvessel density and vascular endothelial growth factor expression as predictors of childrens' survival from cerebellar medulloblastoma.
Tural S; Gercek A; Konya D; Ozgen S; Toplamoglu H; Ozek MM
J Clin Neurosci; 2009 Sep; 16(9):1199-202. PubMed ID: 19524442
[TBL] [Abstract][Full Text] [Related]
13. Medulloblastoma: experience of a single institution.
Wolff JE; Huettermann U; Ritter J; Straeter R; Palm D; Ruebe C; Kraehling KH; Jürgens H
Klin Padiatr; 1998; 210(4):234-8. PubMed ID: 9743958
[TBL] [Abstract][Full Text] [Related]
14. Survivin is a negative prognostic marker in medulloblastoma.
Pizem J; Cört A; Zadravec-Zaletel L; Popovic M
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):422-8. PubMed ID: 16008826
[TBL] [Abstract][Full Text] [Related]
15. Biologic risk stratification of medulloblastoma: the real time is now.
Fisher PG; Burger PC; Eberhart CG
J Clin Oncol; 2004 Mar; 22(6):971-4. PubMed ID: 14970187
[No Abstract] [Full Text] [Related]
16. Panventricular medulloblastoma.
Bhatoe HS; Dutta V; Chaturvedi A
J Neurooncol; 2005 Sep; 74(3):281-2. PubMed ID: 16187024
[No Abstract] [Full Text] [Related]
17. Characteristics and outcomes of medulloblastoma in adults.
Ang C; Hauerstock D; Guiot MC; Kasymjanova G; Roberge D; Kavan P; Muanza T
Pediatr Blood Cancer; 2008 Nov; 51(5):603-7. PubMed ID: 18649371
[TBL] [Abstract][Full Text] [Related]
18. A review of the factors influencing the prognosis of medulloblastoma. The importance of cell differentiation.
Caputy AJ; McCullough DC; Manz HJ; Patterson K; Hammock MK
J Neurosurg; 1987 Jan; 66(1):80-7. PubMed ID: 3783262
[TBL] [Abstract][Full Text] [Related]
19. Medulloblastoma variants and survival at a children's hospital.
Craver R; Sandquist D; Nadell J; Velez M
Fetal Pediatr Pathol; 2011; 30(1):53-9. PubMed ID: 21204667
[TBL] [Abstract][Full Text] [Related]
20. Universal poor survival in children with medulloblastoma harboring somatic TP53 mutations.
Tabori U; Baskin B; Shago M; Alon N; Taylor MD; Ray PN; Bouffet E; Malkin D; Hawkins C
J Clin Oncol; 2010 Mar; 28(8):1345-50. PubMed ID: 20142599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
